GRM5 and Alzheimer disease: Metabotropic glutamate receptor 5 (mGluR5) antagonist MPEP alleviated neuroinflammatory response, promoted autophagy with increased expression of LC3-II and Beclin1, and decreased expression of p62 via PI3K/AKT/mTOR signal in AD mice [40].